Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Siemens Collaborates With EFPIA
A growing menace of pseudo prescription drugs in Europe’s traditional supply chain is very alarming. In order to tackle this, Siemens and EFPIA (European Federation of Pharmaceutical Industries
A growing menace of pseudo prescription drugs in Europe’s traditional supply chain is very alarming. In order to tackle this, Siemens and EFPIA (European Federation of Pharmaceutical Industries
Shire has announced that the FDA has affirmed its prior decision to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire for the treatment
Elron has announced that a non-binding indication of interest of a third party regarding a potential acquisition of Medingo, an Elron subsidiary, has been received. The company claims
A new study published in the Proceedings of the National Academy of Science (PNAS) has identified a new protein, BAHD1, which is responsible for changing DNA structure and
Ceragenix Pharmaceuticalshas provided an update to a previously announced exclusive cooperative research and development with MAST BioSurgery (MAST) for the development of one or more new surgical products
Arena has reported that data from the pivotal BLOOM phase 3 trial demonstrate lorcaserin increased excess weight loss, improved markers of cardiovascular risk and glycemic parameters, and was
Orexigen has announced a new data from the COR-I, COR-II and COR-Diabetes trials for Contrave (bupropion SR/ naltrexone SR) to expand on top-line results announced in July. Contrave
Hovione has acquired an aseptic spray-drying production line, vial filling and back up utilities from Acusphere, a company located in Boston. The equipment includes sterile filtration, aseptic spray
GEA Niro has extended its offerings to include contract manufacturing on extensive cGMP spray drying facilities. The GEA Niro Pharma Test Station is available for developing spray drying
The European Commission has granted marketing authorisation to Novartis for its Exforge HCT, a new 3-in-1 treatment for people with high blood pressure. Exforge HCT combines the efficacy